INTRODUCTION: Excessive use of adrenergic agents may result in stunned myocardium. CASES: We report the cases of two patients with subarachnoid hemorrhage (SAH) complicated by cardiogenic shock secondary to triple-H therapy for cerebral vasospasm. Both patients had normal cardiac function on admission and no signs of acute myocardial infarction at the onset of cardiogenic shock. Intra-aortic balloon pump (IABP) counterpulsation was used to maintain adequate cerebral perfusion while enabling the high doses of norepinephrine that were being administered to be reduced. Reversal of the myocardial dysfunction after vasopressors were discontinued supported a diagnosis of catecholamine-induced stunned myocardium. CONCLUSION: IABP counterpulsation may be one therapeutic option for patients with vasospasm after SAH when high doses of vasopressors can induce severe myocardial dysfunction. However, this invasive device may not be sufficient to maintain adequate cerebral perfusion and fatal embolic events can complicate the clinical course.
INTRODUCTION: Excessive use of adrenergic agents may result in stunned myocardium. CASES: We report the cases of two patients with subarachnoid hemorrhage (SAH) complicated by cardiogenic shock secondary to triple-H therapy for cerebral vasospasm. Both patients had normal cardiac function on admission and no signs of acute myocardial infarction at the onset of cardiogenic shock. Intra-aortic balloon pump (IABP) counterpulsation was used to maintain adequate cerebral perfusion while enabling the high doses of norepinephrine that were being administered to be reduced. Reversal of the myocardial dysfunction after vasopressors were discontinued supported a diagnosis of catecholamine-induced stunned myocardium. CONCLUSION: IABP counterpulsation may be one therapeutic option for patients with vasospasm after SAH when high doses of vasopressors can induce severe myocardial dysfunction. However, this invasive device may not be sufficient to maintain adequate cerebral perfusion and fatal embolic events can complicate the clinical course.
Authors: André L A J Dekker; Koen D Reesink; Frederik H van der Veen; G Vincent A van Ommen; Gijs G Geskes; A Cecilia M Soemers; Jos G Maessen Journal: Shock Date: 2003-04 Impact factor: 3.454
Authors: N Parekh; B Venkatesh; D Cross; A Leditschke; J Atherton; W Miles; A Winning; A Clague; C Rickard Journal: J Am Coll Cardiol Date: 2000-10 Impact factor: 24.094
Authors: Fabio Silvio Taccone; Alexandre Brasseur; Jean-Louis Vincent; Daniel De Backer Journal: Intensive Care Med Date: 2013-05-15 Impact factor: 17.440
Authors: Benjamin B Kenigsberg; Christopher F Barnett; Jeffrey C Mai; Jason J Chang Journal: Curr Neurol Neurosci Rep Date: 2019-11-13 Impact factor: 5.081
Authors: Nicholas A Morris; Nathan Manning; Randolph S Marshall; E Sander Connolly; Jan Claassen; Sachin Agarwal; David J Roh; J Michael Schmidt; Soojin Park Journal: Neurosurgery Date: 2018-09-01 Impact factor: 4.654
Authors: Airton Leonardo de Oliveira Manoel; Alberto Goffi; Tom R Marotta; Tom A Schweizer; Simon Abrahamson; R Loch Macdonald Journal: Crit Care Date: 2016-01-23 Impact factor: 9.097